About the Journal
Antibody Reports (eISSN 2624-8557) is an international, academic open-access online journal edited by the "Geneva Antibody Facility". It is dedicated to focusing on the technical and experimental validation of recombinant antibodies. Our primary goal is to encourage scientists to publish their experimental results, thereby generating better and more reproducible data in a collaborative manner and promoting the utilization of recombinant antibodies.
Focus and Scope
Antibody Reports (ISSN 2624-8557) focuses on experimental validation of recombinant antibodies. The general aim is to define the specificity of an antibody and which detection techniques it is compatible with. Negative results, when including an adequate positive control, are also valuable. We encourage scientists to publish their experimental results in as much detail as possible, with the philosophy of "one antigen, one technique, one paper".
Open Access Statement
Antibody Reports is a fully open access journal, ensuring all contents are freely accessible online immediately upon publication. We publish under the Creative Commons Attribution (CC BY) license, allowing unrestricted use, distribution, and reproduction with proper citation. Authors retain copyright, and Article Processing Charges (APCs) support the editorial and publishing process.
Article Processing Charges
Antibody report is published by the Bibliothèque de l'Université de Genève (publishing service provider) on behalf of the Geneva Antibody Facility. It is partially supported by public funds and foundations. Our significantly reduced publication fees (CHF 300.-) contribute to covering the expenses associated with publication, including journal production and maintenance.
Manuscripts featuring antibodies produced and/or discovered by the Geneva Antibody Facility will be published free of charge. Collaborators affiliated with the University of Geneva are also exempt from these charges. Authors whose primary affiliation is in countries defined by the World Bank as low- or lower-middle-income are eligible for discounts or waivers on their Article Processing Charge (APC).
Publishing Schedule
Antibody Reports aims to maintain a continuous publication schedule, ensuring that articles are promptly published online as soon as they are ready, with the goal of achieving a rapid release, potentially on a daily basis.
Archiving Policy
This journal ensures the long-term availability of its contents. Articles published in Antibody Reports are automatically deposited in the institutional repository of the University of Geneva, and from there, in the SAFE Private LOCKSS Network managed by 7 universities located on multiple continents, thus ensuring a very high level of preservation.
Antibody reports also encourages the self-archiving of articles after publication by their authors in open-access repositories of their choice, whether it is the submitted version, the accepted version, or the published version of the contribution.
Copyright Notice
Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the journal. By virtue of their appearance in this open access journal, articles are free to use after initial publication under the Creative Commons Attribution 4.0 International licence (CC-BY).
Publisher
This journal is published by the Bibliothèque de l'Université de Genève (publishing service provider) on behalf of the Geneva Antibody Facility using a customized version of the OJS by The Public Knowledge Project (PKP).
